Insider · CIK 0001684191
Ryan McManus
Files at NSYS (NORTECH SYSTEMS INC). First filing -, latest -.
In brief
Ryan McManus files SEC Form 4 as director at NSYS (NORTECH SYSTEMS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ryan McManus has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | NSYS NORTECH SYSTEMS INC | AGrant or award Stock Optionsderivative | +8,000 | $0.00 | $0 | 8,000 | 29 d ago |
| May 19, 2025 | NSYS NORTECH SYSTEMS INC | AGrant or award Common Stock | +6,876 | $8.73 | $60k | 14,857 | May 22, 2025 |
| May 19, 2025 | NSYS NORTECH SYSTEMS INC | AGrant or award Stock Optionsderivative | +6,832 | $0.00 | $0 | 6,832 | May 22, 2025 |
| May 20, 2024 | NSYS NORTECH SYSTEMS INC | AGrant or award Common Stock | +1,981 | $11.06 | $22k | 7,981 | Jul 12, 2024 |
Questions about Ryan McManus
Answered from the filings on this page, as of the latest one.
Is Ryan McManus buying or selling?
Ryan McManus has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ryan McManus's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ryan McManus has 0.
Where does Ryan McManus file Form 4?
Ryan McManus has filed Form 4 at NSYS (NORTECH SYSTEMS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.